Logo image of UTME

UTIME LTD (UTME) Stock Fundamental Analysis

USA - NASDAQ:UTME - KYG9411M1087 - Common Stock

0.478 USD
-0.01 (-1.42%)
Last: 9/1/2023, 8:00:02 PM
0.478 USD
0 (0%)
After Hours: 9/1/2023, 8:00:02 PM
Fundamental Rating

0

Overall UTME gets a fundamental rating of 0 out of 10. We evaluated UTME against 125 industry peers in the Electronic Equipment, Instruments & Components industry. UTME has a bad profitability rating. Also its financial health evaluation is rather negative. UTME does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UTME has reported negative net income.
UTME had a negative operating cash flow in the past year.
In the past 5 years UTME always reported negative net income.
In the past 5 years UTME reported 4 times negative operating cash flow.
UTME Yearly Net Income VS EBIT VS OCF VS FCFUTME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

UTME has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UTME Yearly ROA, ROE, ROICUTME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

With a Gross Margin value of 13.01%, UTME is not doing good in the industry: 70.40% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of UTME has grown nicely.
UTME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y14.27%
UTME Yearly Profit, Operating, Gross MarginsUTME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

More info and screens

0

2. Health

2.1 Basic Checks

UTME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UTME has been increased compared to 1 year ago.
UTME has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UTME is higher compared to a year ago.
UTME Yearly Shares OutstandingUTME Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
UTME Yearly Total Debt VS Total AssetsUTME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

UTME has an Altman-Z score of -0.71. This is a bad value and indicates that UTME is not financially healthy and even has some risk of bankruptcy.
UTME has a worse Altman-Z score (-0.71) than 84.80% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that UTME has dependencies on debt financing.
The Debt to Equity ratio of UTME (1.38) is worse than 92.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACCN/A
WACC10.98%
UTME Yearly LT Debt VS Equity VS FCFUTME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

UTME has a Current Ratio of 0.96. This is a bad value and indicates that UTME is not financially healthy enough and could expect problems in meeting its short term obligations.
UTME has a worse Current ratio (0.96) than 91.20% of its industry peers.
UTME has a Quick Ratio of 0.96. This is a bad value and indicates that UTME is not financially healthy enough and could expect problems in meeting its short term obligations.
UTME's Quick ratio of 0.90 is on the low side compared to the rest of the industry. UTME is outperformed by 81.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.9
UTME Yearly Current Assets VS Current LiabilitesUTME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

UTME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.23%.
The Revenue for UTME has decreased by -12.81% in the past year. This is quite bad
UTME shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.85% yearly.
EPS 1Y (TTM)-62.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.04%
Revenue 1Y (TTM)-12.81%
Revenue growth 3Y1.27%
Revenue growth 5Y-11.85%
Sales Q2Q%-27.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UTME Yearly Revenue VS EstimatesUTME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UTME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UTME Price Earnings VS Forward Price EarningsUTME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UTME Per share dataUTME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UTME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UTIME LTD

NASDAQ:UTME (9/1/2023, 8:00:02 PM)

After market: 0.478 0 (0%)

0.478

-0.01 (-1.42%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners0.52%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-1.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS3.3
BVpS0.44
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.01%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y14.27%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.05%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.9
Altman-Z -0.71
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)80.3%
Cap/Depr(5y)214.37%
Cap/Sales(3y)1.49%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.81%
Revenue growth 3Y1.27%
Revenue growth 5Y-11.85%
Sales Q2Q%-27.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-148%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.45%
OCF growth 3YN/A
OCF growth 5YN/A